Expired contract

PHE_Scientific_Development of an Ovine Polyclonal Immunoglobulin Therapy.

Details

Buyer: Public Health England
Supplier(s): The Native Antigen Company Limited
Value: £26,523
Duration: 1 year
Topic: Peptones and protein substances
Published: 9 February 2021
Source: uk:contracts_finder

Tender description

This requirement was to develop a rapid and effective therapy against infection by developing an ovine immunoglobulin treatment against the spike protein of Covid 19. Additional information: PHE discharges its duties as a Category 1 Responder to emergencies on behalf of the Secretary of State for Health within the scope of the Civil Contingencies Act 2004 (CCA 2004). This urgent requirement is in response to the COVID -19 outbreak for the research of therapeutic antibodies.

Timeline

Completed: Award date17 April 2020
Completed: Award published9 February 2021
Current notice
Completed: Contract expiry date16 April 2021

About the buyer

Public Health England is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.

Decision makers

Connect with the people behind this procurement.

Job title	Phone number	Work email
Head of Procurement	+44 •••• ••••••	••••••••@public-health-england.gov
Commercial Director	+44 •••• ••••••	••••••••@public-health-england.gov
Procurement Manager	+44 •••• ••••••	••••••••@public-health-england.gov
Category Lead	+44 •••• ••••••	••••••••@public-health-england.gov
Senior Buyer	+44 •••• ••••••	••••••••@public-health-england.gov
Contracts Manager	+44 •••• ••••••	••••••••@public-health-england.gov